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Abstract While collateral sprouting has been shown to oc-
cur in a variety of neuronal populations, the factor or fac-
tors responsible for mediating the sprouting response re-
main largely un-defined. There is evidence indicating that
ciliary neurotrophic factor (CNTF) may play an important
role in promoting neuronal survival and process outgrowth
in neuronal phenotypes tested to date. We previously dem-
onstrated that the astrocytic Jak-STAT pathway is necessary
to mediate CNTF-induced oxytocinergic (OT) neuronal sur-
vival; however, the mechanism (s) of CNTF-mediated pro-
cess outgrowth remain unknown. Our working hypothesis
is that CNTF mediates differential neuroprotective re-
sponses via different intracellular signal transduction path-
ways. In order to test this hypothesis, we utilized stationary
hypothalamic organotypic cultures to assess the contribu-
tion of the MAPK-ERK and PI3-AKT pathways to OT
neuron survival and process outgrowth. Our results demon-
strate that the MAPK-ERK½ pathway mediates CNTF-
induced neuronal survival. Moreover, we show that inhibi-
tion of the p38-, JNK-MAPK, and mTOR pathways pre-
vents loss OT neurons following axotomy. We also provide
quantitative evidence indicating that CNTF promotes pro-
cess outgrowth of OT neurons via the PI3K-AKT pathway.
Together, these data indicate that distinct intracellular
signaling pathways mediate diverse neuroprotective pro-
cesses in response to CNTF.
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Collateral axonal sprouting has been shown to occur in a va-
riety of neuronal populations within the central nervous sys-
tem although the factors responsible for mediating axonal
sprouting are still largely ill-defined. However, there is grow-
ing evidence indicating that ciliary neurotrophic factor
(CNTF) plays an important role. For example, CNTF has been
shown to promote axonal sprouting of hypothalamic
magnocellular neurons in vitro (Askvig et al. 2013; Vutskits
et al. 1998) and motor neuron sprouting in vivo (Gurney et al.
1992; Guthrie et al. 1997; Kwon and Gurney 1994; Oyesiku
and Wigston 1996; Siegel et al. 2000; Simon et al. 2010;
Ulenkate et al. 1994; Wright et al. 2007; Xu et al. 2009).
Moreover, CNTF promotes the survival of magnocellular neu-
rons in the paraventricular nucleus (PVN) and supraoptic nu-
cleus (SON) of the magnocellular neurosecretory system in
organotypic cultures (Askvig et al. 2013; House et al. 2009;
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Rusnak et al. 2002; Rusnak et al. 2003; Vutskits et al. 1998;
Vutskits et al. 2003).
To induce a cellular response, CNTF first binds to a three-
part receptor complex consisting of the ligand-specific bind-
ing subunit CNTF receptor alpha (CNTFRα), which is at-
tached to the membrane via a glycosylphosphatidylinositol
(GPI) linkage. The CNTF-CNTFRα complex then interacts
with glycoprotein 130 (gp130) and leukemia inhibitory factor
receptor beta (LIFRß) (Davis et al. 1993; Ip et al. 1993; Ip
et al. 1992; Schuster et al. 2003) to form a functional trans-
membrane signaling complex. We have demonstrated previ-
ously that astrocytes within the SON are immunoreactive for
CNTFRα, LIFRß, gp130 and CNTF protein (Askvig et al.
2012; Watt et al. 2006). However, magnocellular neurons
are immunoreactive for CNTFRα and gp130 (Askvig et al.
2012; Watt et al. 2009) but not LIFRß indicating that the
astrocytes but not magnocellular neurons of the SON are ac-
tivated directly by CNTF (Davis et al. 1993). In support of this
observation, we have shown that pressure injection of exoge-
nous rat recombinant (rrCNTF) into the SON in vivo results in
phosphorylation of STAT3 in astrocytes but not magnocellular
neurons (Askvig et al. 2013). CNTF-induced activation of the
Jak-STAT pathway mediates a significant increase in survival
of axotomized magnocellular neurons in organotypic culture
which was reduced by pharmacological inhibition of the Jak-
STAT pathway (Askvig et al. 2013). In addition, we observed
an extensive outgrowth of neuronal processes originating
from oxytocinergic (OT) neurons in the SON and PVN in
response to rrCNTF (Askvig et al. 2013). Together, these data
indicate that CNTF-induced survival of OT magnocellular
neurons is mediated through a paracrine interaction with as-
trocytes. Although the specific intracellular pathway (s) which
mediate CNTF-induced process outgrowth remain unknown,
others have demonstrated differential effects of the Jak-STAT,
PI3-AKT and MAPK-ERK pathways in mediating neuronal
survival versus process outgrowth (Alonzi et al. 2001; Dolcet
et al. 2001; Ozog et al. 2008; Sango et al. 2008).
Our working hypothesis is that CNTF mediates neuronal
survival and process outgrowth via different intracellular sig-
nal transduction pathways, respectively. In order to test this
hypothesis, we utilized stationary hypothalamic organotypic
cultures, as initially developed by Stoppini et al. (1991), to
assess the contribution of the MAPK, NFkB and PI3-AKT
pathways to magnocellular neuron survival and process out-
growth in the SON and PVN. Organotypic cultures exhibit
several advantages over other in vitro culture systems primar-
ily because of the preservation of the in vivo cytoarchitecture
and the use of fully differentiated neurons (House et al. 1998;
Vutskits et al. 1998). Furthermore, the ability to directly ma-
nipulate the culture media with growth factors and pharmaco-
logical agents and assess magnocellular neuron survival in
hypothalamic organotypic cultures facilitates analysis of
pathway-mediated cellular events more rapidly than can be
achieved using in vivo injury model systems. However, as
with all in vitro systems when interpreting experimental re-
sults consideration must be given to alteration of cellular ac-
tivities specific to the tissue preparation and culture conditions
used which may affect experimental outcomes. Nevertheless,
stationary organotypic cultures provide a unique and powerful
tool for exploring the factors and mechanisms through which
specific central nervous systems respond to injury
Materials and methods
Animals
Pregnant Sprague Dawley rats (E15) were purchased from
Harlan Laboratories (Minneapolis, MN). All rats were housed
in the University of North Dakota Center for Biomedical Re-
search Facility, an AAALAC accredited facility, under a
12 L:12D light cycle with ad lib access to lab chow and tap
water throughout the investigations. Experimental protocols
utilized in these studies followed the guidelines in the NIH
guide for the care and use of laboratory animals and were
approved by the UND Institutional Animal Care and Use
Committee. All efforts were made to minimize the numbers
of animals used in this study and their suffering.
Stationary hypothalamic organotypic cultures
Organotypic cultures were prepared as previously described
(Askvig et al. 2013). Briefly, 6-day-old Sprague Dawley rat
pups were decapitated and their brains were removed and
placed in chilled Geys Balanced Salt Solution (Gibco, Grand
Island, NY) enriched with glucose (5 mg/ml; Sigma). The
brains were then trimmed to remove exterior cortical material
and 350 μm coronal sections obtained using a McIlwain Tis-
sue Chopper (Stoelting). The sections containing the
magnocellular neurosecretory system nuclei were placed in
chilled Geys Balanced Salt Solution and then trimmed dorsal
to the third ventricle and lateral to the SON under a dissecting
microscope. Sections from each animal were then placed on a
single Millicell-CM filter insert (pore size 0.4 μm, 30 mm
diameter; Millipore, Bedford, MA) and each filter insert was
then placed in a 35×10 mm Petri dish containing 1.1–1.2 ml
of culture media for the experimental period.
Media and incubations
The culture media was made fresh at the beginning of every
experiment and consisted of Eagle’s Basal Medium with
Earle’s salts (50 %; Gibco), heat inactivated horse serum
(25 %; Gibco), Hank’s balanced salt solution (25 %; Gibco),
glucose (0.5 %; Sigma), penicillin/streptomycin (25 units/ml;
Gibco), and glutamine (1.0 mM; Gibco). The osmolality and
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pH of the culture media were measured from the stock media
solution every 48 h using a Wescor vapor pressure osmometer
(Wescor 5500; Logan, UT) and a mini pHmeter (IQ Scientific
Instruments, Loveland, CO), respectively. Our analysis dem-
onstrated that the media osmolality was maintained at 310.5±
0.45 mOsm/l and the pH was at 8.2±0.03 throughout the
experimental period. Incubation of the cultures was stationary
in 5 % CO2-enriched air at 35 °C for the entire experimental
period.
Hypothalamic slices were cultured in the presence or
absence of rrCNTF (#C3835, lot #080 M1730 or
#091 M1403, Sigma) for 14 days. All groups had their
culture media replaced every 48 h and always received
fresh additions of rrCNTF. Inhibition experiments were
performed by administering the inhibitor in the absence
of rrCNTF for 1 h prior to treatment of the cultures follow-
ed by replacement with media containing the inhibitor plus
rrCNTF for the duration of the experimental period. Addi-
tional control cultures received only the inhibitor for the
entire experimental period. Multiple inhibitors, which had
distinct mechanisms of action, were used to inhibit the
pathways. The concentrations used for each inhibitor was
determined from previous reports of others indicating op-
timal working concentrations of inhibitors used in primary
cell cultures (Phulwani et al. 2008; Su et al. 2011; Wang
et al. 2008), or when available, in organotypic cultures
(Greenwood and Bushell 2010; Luo et al. 2007; Marwarha
et al. 2010; Ohnishi et al. 2010; Rusnak and Gainer 2005;
Zamin et al. 2006). Briefly, inhibition of various compo-
nents of the MAPK pathway were inhibited with U0126,
PD98059, PD184352, SP600125, and SB203580, the
PI3K-AKT pathway was inhibited with LY294002 and
wortmannin, mTOR signaling was inhibited utilizing
rapamycin and torin-1, and the NFκB transcription factor
was inhibited by bay 11-7082 and sc-514 (Table 1).
Organotypic culture immunohistochemistry
Following experimental periods, the explants were prepared
for immunohistochemistry with fixation in 4 % paraformalde-
hyde (Sigma) in 0.1 M phosphate buffer for 1.5 h. For immu-
nohistochemical analysis, sections were washed with PBS-T
in 3×10 min intervals before and after all incubations. For
single-label peroxidase immunohistochemistry, endogenous
peroxidase activity and non-specific staining were prevented
by treatment with 0.3%H2O2 (Sigma) followed by incubation
in blocking buffer (10% normal horse serum containing 0.3%
Triton X-100) for 1 h. The explants were then incubated for
36 h at 4 °C in a highly specific monoclonal mouse antibody
against oxytocin (OT)-neurophysin (PS 38, 1:500; a gift from
Dr. Harold Gainer). This antibody was first characterized by
Ben-Barak et al. (1985) and has been shown to label specifi-
cally OT neurons and their processes within stationary
organotypic cultures prepared from rat hypothalamus (House
et al. 2009; House et al. 2006; House et al. 1998; Rusnak et al.
2002; Rusnak et al. 2003; Shahar et al. 2004; Vutskits et al.
1998; Vutskits et al. 2003). Next the cultures were incubated
in horse anti-mouse biotinylated secondary antibody (1:500;
Vector), followed by avidin-biotin complex (ABC; 10μl/ml in
PBS; Vector ABC Elite kit) for 1 h at room temperature.
Bound antibodies were visualized using 0.05 % diaminoben-
zidine (DAB, Sigma) in PBS developed through the glucose-
oxidase method (Itoh et al. 1979). The hypothalamic slices
were then removed from their filters and placed directly on
gelatin coated slides. All slides were then dehydrated in in-
creasing concentrations of alcohol followed by xylene and
coverslips mounted with Permount (Fisher, Pittsburgh, PA).
All images were captured using an Olympus BX-51 light mi-
croscope with attached DP-71 color camera and dedicated
software. Montage images were prepared for reproduction
using the ‘photomerge’ option in Adobe Photoshop CS3.
Table 1 Pharmacological
inhibitors used in this study Inhibitor (Concentration used) Site of action Source/Cat #
Bay 11-7082 (15, 30 μM) IκBα Calbiochem # 196870
LY294002 (15 μM) PI3K Calbiochem #440202
LY303511 (15 μM) Negative control for LY294002. Calbiochem # 440203
PD184352 (5 μM) MEK½ Santa Cruz #sc-202759
PD98059 (5 μM) MEK½ and MEK5 Calbiochem #513000
Rapamycin (10 μM) mTORC1 Calbiochem #553210
SB203580 (75 μM) p38 MAPK Calbiochem # 559389
SC-514 (20 μM) Iκκ-2(ß) Calbiochem # 401479
SP600125 JNKII Inhibitor (50 μM) c-Jun N-terminal kinase (JNK) Calbiochem # 420119
Torin-1 (500 nM) mTORC1 and mTORC2 Tocris (R&D Systems) #4247
U 0124 (1 μM) Negative control for U 0126. Calbiochem # 662006
U 0126 (1 μM) MEK½ and MEK5 Calbiochem # 662005
Wortmannin (KY12420) (1 μM) PI3K Calbiochem # 681675
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Magnocellular neuronal counts
The slides containing the immunoreactive explant culture
slices were coded by a third party blind to the experimental
conditions. In order to obtain the total number of neurons in
the PVN and SON, immunoreactive cells were counted using
a drawing tube attached to an Olympus BX51 microscope.
The values used in statistical analysis represent the total num-
ber of immunoreactive neurons for each nuclei of one neonatal
hypothalami (i.e., one filter insert) and it was the mean of two
individual’s independent neuronal counts that were used as the
group mean for statistical analysis as described below.
Quantitative analysis of process density
In order to quantify the extent of OT-immunoreactive process
outgrowth originating from the SON in organotypic cultures,
we utilized a previously described stereological analysis tech-
nique first developed for quantification of neurite outgrowth
from chick dorsal root ganglion (Bilsland et al. 1999) and
modified for our culture system. Slides coded by a third party
blind to the experimental conditions were viewed at 10× mag-
nification using an Olympus BX51 microscope. In order to
ensure consistency across groups, the SON was placed in the
lower center frame of the picture (1360×1024 image size) and
the frame digitally captured. MCID image analysis software
(Cambridge, England) was used to quantify the area occupied
by OT-immunoreactive processes using an automatic target
detection and measurement feature that quantifies the area in
pixels occupied by a target according to the defined target
criteria (Bilsland et al. 1999). The target criteria are set com-
bining the optical density and spatial characteristics of the
target. Once the density was set, any pixel falling within this
range in the image was automatically counted. A full image
scan of the micrograph was performed which gave the propor-
tional area of the entire micrograph that was occupied by OT-
immunoreactivity (total proportional area). Next, the density
was determined for the immunoreactive somata, which gave
the somata proportional area. The somata proportional area
was subtracted from the total proportional area to determine
the proport ional area that was occupied by OT-
immunoreactive processes (process proportional area), which
was the value that was utilized in the statistical analysis. As
each organotypic culture differs in terms of intensity of immu-
noreactivity and background, the density was set for each
image before quantification was undertaken. Since each
SON varies in the amount of magnocellular neurons, we
corrected for the number of neurons in the SON by standard-
izing the process proportional area to the total number of neu-
rons in the SON. Thus, the values utilized for statistical anal-
yses, as described below, represent the ratio of process pro-
portional area to total number of neurons in the SON.
Statistical analysis
Distribution normality of each group of data was tested using
the Kolmogorov-Smirnov test (GraphPad InStat, version 3.06
for Windows; San Diego California) and all groups were nor-
mally distributed. Statistical differences between groups were
compared using one-way ANOVAwith Tukey’s post hoc test
(GraphPad InStat) with p<0.05 considered statistically signif-
icant. Statistical values are reported in the appropriate figure
legends. Results are expressed as the group means ± SD.
Results
The MAPK-ERK pathway mediates CNTF-induced
OTneuronal survival in organotypic cultures
Three pharmacological inhibitors of the MAPK-ERK path-
way were utilized; U0126, PD98059, and PD184352
(Table 1). All inhibit MAPKK (MEK), preventing activation
of the immediate downstream target, ERK. U0126 and
PD98059 are structurally related, and have been demonstrated
to inhibit both MEK½ and MEK5 (Ballif and Blenis 2001; Su
et al. 2011), while PD184352 specifically inhibits MEK½
(Bain et al. 2007). Organotypic cultures were also treated with
U0124, which is a control molecule for the pharmacological
inhibitor, U0126, and does not inhibit MEK activity even at
concentrations of 100 μM (manufacturer’s technical sheet).
Our results indicate that treatment of organotypic cultures
with rrCNTF, (25 ng/ml, 14 days) (Askvig et al. 2013), result-
ed in a 443 % increase in the number of surviving OT neurons
in the SONwhen compared with control values obtained from
cultures maintained in rrCNTF-free media (Fig. 1a). Addition-
ally, a significant 52 % increase in OT neuronal survival was
also observed in the PVN (Fig. 1b).
When cultures were treated with 25 ng/ml rrCNTF in the
presence of U0124, the control molecule, there was no signif-
icant difference in the number of surviving OT neurons in the
SON or PVN (Fig. 1). In contrast, when the MEK½ and
MEK5 pathways were inhibited with 1 μM U0126 in the
presence of rrCNTF we observed a 55 and 40 % decrease in
the number of surviving OT neurons in the SON and PVN,
respectively (Fig. 1a and b). Likewise, CNTF treatment in the
presence of PD98059 resulted in an 80 and 65 % decrease in
the number of surviving OT neurons in the SON and PVN,
respectively (Fig. 1b).
When cultures were treated with PD184352 in the presence
of rrCNTF we observed an 84 and 53 % decrease in OT
neurons in the SON and PVN, respectively (Fig. 1b). When
organotypic cultures were treated with inhibitors alone there
was no significant difference in the number of OT neurons in
the SON or PVN (Fig. 1b) demonstrating that the inhibitors
alone did not adversely affect OT neuron survival. Together,
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these data demonstrate that pharmacological inhibition of the
MAPK pathway prevented CNTF-induced survival of OT
neurons in the SON and PVN.
JNK-MAPK and p38 do not mediate CNTF-induced neuronal
survival
For the pharmacological inhibition of the p38-MAPK
pathway, we utilized SB203580, which inhibits the p38α
and ß isoforms, but not the γ and δ isoforms, and does
not inhibit any of the JNK- or ERK-MAPK isoforms (En-
glish and Cobb 2002; Greenwood and Bushell 2010; Lee
et al. 1994). Our analysis demonstrated that SB203580 in
the presence of rrCNTF did not adversely affect neuronal
survival in the SON or PVN (Fig. 2a and b). Conversely,
treatment of cultures with inhibitor alone resulted in a 184
and 72 % increase in the number of OT neurons in the
SON and PVN, respectively (Fig. 2a and b) suggesting
that the p38-MAPK pathway mediates injury-induced cell
death of OT neurons.
We next applied SP600125 (JNK Inhibitor II) which has
equal potency towards all three of the JNK isoforms (JNK1-3)
and cJun (Bennett et al. 2001; Ohnishi et al. 2010). Results
indicate that SP600125 in the presence of rrCNTF did not
adversely affect CNTF-induced neuron survival in the SON
(Fig. 2a). However, in the PVN, we observed a 66 % increase
in surviving OT neurons following treatment with SP600125
in the presence of rrCNTF. Treatment with SP600125 alone
resulted in a 194 % increase in OT neuron survival the SON
(Fig. 2a) and by 125 % in the PVN (Fig. 2b).
The PI3K-AKT pathway mediates CNTF-induced process
outgrowth
Two pharmacological inhibitors of PI3K were utilized;
LY294002, which blocks the ATP binding site of PI3K
(Zamin et al. 2006), and wortmannin (KY12420), which
blocks the catalytic activity of PI3K (Luo et al. 2007). In
addition, LY303511, which contains a single atom substitu-
tion in the morpholine ring and does not inhibit PI3K at con-
centrations up to 100μM (manufacturer’s technical sheet) was
used as a control for LY294002. We found that treatment with
LY303511, LY294002 or wortmannin in the presence of
rrCNTF did not result in a significant difference in the number
of surviving OT neurons in the SON or PVN, although the
number of surviving OT neurons were still significantly ele-
vated from non-CNTF treated control (Fig. 3a and b). When
organotypic cultures were treated with inhibitors alone there
was no difference in the number of OT neurons in the SON or
PVN. Together, these data demonstrate that pharmacological
inhibition of the PI3K-AKT pathway does not affect CNTF-
Fig. 1 The MAPK-ERK½ pathway is necessary to mediate the CNTF-
induced survival of OT neurons. Immunohistochemical neuronal cell
counts demonstrated that exogenous rrCNTF promoted the survival of
OT neurons (SON: p<0.0001; PVN: p<0.0001) compared to control,
while inhibition of the MAPK-ERK½ pathway with U0126 (SON: p<
0.0001; PVN: p<0.0001), PD98059 (SON: p<0.0001; PVN: p<
0.0001), and PD184352 (SON: p<0.0001; PVN: p<0.0001) significant-
ly reduced the number of surviving OT neurons in the SON (a) and PVN
(b) compared to the 25 ng/ml rrCNTF group. Column bars and error bars
represent the mean and SD of [n] groups. PVN, paraventricular nucleus;
SON, supraoptic nucleus. ***p<0.0001
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induced OT neuronal survival in hypothalamic organotypic
explant cultures.
When visibly comparing the number of OT neurons
between cultures treated with rrCNTF (Fig. 3c and inset),
and rrCNTF plus LY294002 (Fig. 3d and inset), it is ap-
parent that although there are similar numbers of OT neu-
rons present there are fewer neuronal processes present in
the groups receiving PI3K inhibition. Therefore, we uti-
lized quantitative optical densitometric stereological anal-
ysis to determine the proport ional area of OT-
immunoreactive processes in the SON. Figure 4 illustrates
the procedure. The value utilized in the statistical analysis
was the ratio of the process proportional area to the total
number of neurons in the SON. Our results demonstrate
that following administration of exogenous rrCNTF there
was a 112 % increase in the proportional area of OT-
immunoreactive processes compared to control (Fig. 4d).
LY303511 plus rrCNTF group did not differ from the
rrCNTF group (Fig. 4d). However, when the PI3K inhib-
itors, LY294002 and wortmannin, were administered to
the organotypic cultures in the presence of rrCNTF, there
was a significant reduction in the proportional area of OT-
immunoreactive processes in the SON (Fig. 4d). More-
over, the LY294002 plus rrCNTF group was significantly
reduced from control values (Fig. 4d). These observations
demonstrate that while PI3K signaling does not influence
CNTF-mediated neuronal survival, it does mediate CNTF-
induced process outgrowth of OT magnocellular neurons
in the SON.
mTORC1 and C2 do not mediate CNTF-induced neuronal
survival or process outgrowth
Rapamycin is a selective and potent inhibitor of mTOR
complex 1 (mTORC1) (Marwarha et al. 2010), we also
utilized torin-1, which is a selective and potent inhibitor
for both mTORC1 and mTORC2 (Thoreen et al. 2012;
Thoreen et al. 2009; Thoreen and Sabatini 2009). More-
over, torin-1 has been demonstrated to provide more com-
plete inhibition of mTORC1 when compared to rapamycin
(Thoreen and Sabatini 2009). Our analysis demonstrated
that 10 μM rapamycin or 500 nM torin-1 in the presence
of rrCNTF did not result in a statistically significant differ-
ence in the number of surviving OT neurons in the SON or
PVN (Fig. 5a and b).
When organotypic cultures were treated with rapamycin or
torin-1, in the absence of rrCNTF, there was a statistically
significant increase in the number of OT neurons in the
Fig. 2 The p38- and JNK-MAPK pathways are not necessary to mediate
the CNTF-induced survival of OT neurons. Immunohistochemical neu-
ronal cell counts demonstrated that exogenous rrCNTF promoted the
survival of OT neurons (SON: p<0.0001; PVN: p<0.05) compared to
control, while inhibition of the p38- and JNK-MAPK pathways with
SB203580 (SON: p<0.0001; PVN: p<0.0001) and SP600125 (SON: p
<0.0001; PVN: p<0.0001), respectively, did not affect the number of
surviving OT neurons in the SON (a) or PVN (b) compared to the
25 ng/ml rrCNTF group. However, when cultures were treated with the
inhibitors alone, there was a statistically significant increase in the num-
ber of surviving OT neurons in the SON (A; SB203580: p<0.0001;
SP600125: p<0.0001) and PVN (B; SB203580: p<0.05; SP600125: p
<0.0001) compared to control. Column bars and error bars represent the
mean and SD of [n] groups. PVN paraventricular nucleus, SON supraop-
tic nucleus. *p<0.05, ***p<0.0001
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SON and PVN. These results suggest that mTOR signaling
may be involved in the injury-induced cell death process in
hypothalamic organotypic cultures. However, in contrast to
inhibition of PI3K, quantitative optical densitometric analysis
demonstrated that pharmacological inhibition of mTOR with
rapamycin or torin-1 did not result in a statistically significant
difference in the proportional area of OT-immunoreactive pro-
cesses in the SON (data not shown).
NF-κB does not mediate CNTF-induced neuronal survival
or process outgrowth
We utilized two pharmacological agents to inhibit NF-κB.
BAY 11-7082, acts by inhibiting IκBα phosphorylation
(Phulwani et al. 2008) while SC-514 targets the IKK complex
which consists of three subcomponents, IKKα , IKKβ , and
IKKγ. SC-514 highly specific for the IKKβ component and
Fig. 3 The PI3K-AKT pathway
is not necessary to mediate the
CNTF-induced survival of OT
neurons. Immunohistochemical
neuronal cell counts demonstrated
that exogenous rrCNTF promoted
the survival of OT neurons (SON:
p<0.0001; PVN: p<0.01)
compared to control, while
inhibition of the PI3K-AKT
pathway with LY294002 (SON:
p=0.6014; PVN: p=0.4931) did
not affect the number of surviving
OT neurons in the SON (a) or
PVN (b) compared to 25 ng/ml
rrCNTF. In addition, the presence
of wortmannin did not affect the
number of surviving OT neurons
in the SON (A; p=0.8791);
although there was a statistically
significant increase in the number
of surviving OT neurons in the
PVN (B; p=0.0373) compared to
the 25 ng/ml rrCNTF group
When visibly comparing the
number of OT neurons between
rrCNTF (c) and the rrCNTF plus
LY294002 (d) groups, it is
apparent that there are fewer
neuronal processes present in the
groups receiving PI3K inhibition
compared to the rrCNTF group,
even though they have the same
number of surviving OT neurons
(compare insets in C and D). Note
that the representative images
were obtained from
approximately the same level of
the magnocellular neurosecretory
system, which is apparent when
comparing the III ventricle
between the images. Column bars
and error bars represent the mean
and SD of [n] groups. ACC
accessory nuclei, PVN
paraventricular nucleus, SON
supraoptic nucleus. Scale bar C,
D=300 μm, inset=100 μm. *p<
0.05, **p<0.01, ***p<0.0001
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shows little effect on the other isoforms in vitro . Our analysis
demonstrated that neither bay 11-7082 nor sc-514 in the pres-
ence of 25 ng/ml rrCNTF resulted in a significant difference in
the number of surviving OT neurons in the SON or PVN
(Fig. 6a and b). Moreover, quantitative analysis demonstrated
that pharmacological inhibition of NF-κB with bay 11-7082
did not result in a significant difference in the proportional
area of OT-immunoreactive processes in the SON compared
to the 25 ng/ml rrCNTF group (data not shown). When
organotypic cultures were treated with bay 11-7082 in the
absence of rrCNTF there was no difference in the number of
OT neurons in the SON. In contrast, when organotypic
cultures were treated with sc-514 in the absence of rrCNTF
a 181 and 166 % increase in the number of OT neurons in the
SON and PVN, respectively was observed indicating that ac-
tivation of the NF-κB complex via a specific IKKβ compo-
nent may promote neuronal loss.
Discussion
Our results indicate that MAPK, PI3-Akt and Jak-Stat
pathways are activated in response to exogenous CNTF
and these pathways mediate differentially neuronal
Fig. 4 Inhibition of PI3K reduces the proportional area of OT-
immunoreactive processes in the SON. a The image of the SON, captured
such that the entire SON is centered in the bottom of the image. b A
highlighted SON is shown following setting of the density. The density
has been set to highlight the immunoreactive processes and somata, how-
ever, note that the analysis is a conservative estimate of the proportional
area of neuronal processes because not all of the immunoreactive process-
es are highlighted (arrowheads, A, B). c A highlighted SON is shown
following the setting of the density to highlight just the immunoreactive
somata. Note that similar to their immunoreactive profiles, the nuclei are
not highlighted by the density setting (arrows, A, C). d The ratio of
proportional area of OT-immunoreactive processes to total number of
neurons in the SON demonstrated that following administration of
exogenous rrCNTF there was a significant increase of 112 % in the
proportional area of OT-immunoreactive processes compared to control
(p<0.0001). The LY303511 molecule served as a control molecule for
the LY294002 inhibitor and the proportional area of OT-immunoreactive
processes in the LY303511 in conjunction with 25 ng/ml rrCNTF group
did not differ from the 25 ng/ml rrCNTF group (p=0.6496). However,
when the PI3K inhibitors, LY294002 andwortmannin, were administered
to the organotypic cultures in the presence of 25 ng/ml rrCNTF, there was
a significant reduction in the proportional area of OT-immunoreactive
processes in the SON compared to the 25 ng/ml rrCNTF group (p<
0.0001). Column bars and error bars represent the mean and SD of [n]
groups. Scale bar=100 μm. **p<0.01, ***p<0.0001
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survival and axonal regeneration by magnocellular neu-
rons. While the Jak-STAT pathway is considered the ca-
nonical CNTF signal transduction pathway, CNTF has
also been demonstrated to activate other intracellular sig-
naling pathways including, MAPK, PI3K, and NFkB
(Bonni et al. 1993; Cagnon and Braissant 2009; Dolcet
et al. 2001; Gallagher et al. 2007; Kassen et al. 2009;
Loy et al. 2011; Lutticken et al. 1994; Muller et al. 2009;
Park et al. 2004; Peterson et al. 2000; Rhee et al. 2004;
Sango et al. 2008; Symes et al. 1994; Trimarchi et al.
2009). For example, CNTF activates the MAPK pathway
via SH2 domain-containing proteins, including SHP2 and
Shc, which are bound to the LIFR and gp130 compo-
nents of the CNTF receptor complex (Giordano et al.
1997; Stahl et al. 1995). Consistent with our findings
others have demonstrated that the MAPK-ERK½ path-
way promotes neuronal survival following injury
(Chicoine and Bahr 2007; Jover-Mengual et al. 2007;
Nagata 1999), primarily through the inhibition of the
pro-apoptotic molecule BAD and production of the
anti-apoptotic molecules, Bcl-2 and Bcl-xL (Nagata
1999). Our studies extend these observations by demon-
strating that the MAPK-ERK½ pathway mediates CNTF-
induced neuronal survival in the magnocellular neurose-
cretory system in vitro. Functional activation of the
MAPK-ERK½ pathway may occur via two potential
mechanisms. First, unlike Jak molecules, which are tyro-
sine kinases, members of the MAPK pathway are serine/
threonine kinases. Thus, MAPK-dependent activation of
STAT3 occurs at Ser727 as opposed to the more common-
ly Jak-dependently phosphorylated Tyr705 (Decker and
Kovarik 2000). However, following pressure injection
of exogenous rrCNTF in to the SON, we observed
STAT3 activation specifically at the Tyr705 residue
(Askvig et al. 2013) indicating that MAPK-ERK½ path-
way is not upstream of STAT3 activation in the astro-
cytes. Alternatively, activation of the Jak-STAT pathway
may lead to activation of the MAPK-ERK½ pathway
(Frank et al. 1995; Ihle and Kerr 1995; Winston and
Hunter 1996). This mechanism appears to be dependent
on Jak-mediated Ras or Raf activation of ERK½. While
Jak-mediated activation of STAT molecules has been re-
ported to be Ras-independent, Jak-mediated activation of
the MAPK-ERK½ pathway has been demonstrated to be
Ras-dependent (Winston and Hunter 1995). Others have
demonstrated that Raf physically associates with Jak2,
and Raf is tyrosine phosphorylated when co-expressed
with Jak2 (Xia et al. 1996) raising the possibility of
CNTF activation of both pathways in parallel following
exogenous CNTF.
Fig. 5 mTOR is not necessary to mediate CNTF-induced survival of OT
neurons. Immunohistochemical neuronal cell counts demonstrated that
exogenous rrCNTF promoted the survival of OT neurons (SON: p<
0.0001; PVN: p<0.0001) compared to control, while inhibition ofmTOR
with rapamycin (SON: p=0.1113; PVN: p=0.6633) and torin-1 (SON:
p=0.1487; PVN: p=0.4250) did not affect the number of surviving OT
neurons in the SON (a) or PVN (b) compared to 25 ng/ml rrCNTF.
However, when cultures were treated with the inhibitors alone, there
was a significant increase in the number of surviving OT neurons in the
SON (A; rapamycin: p<0.0001; torin-1: p<0.0001) and PVN (B;
rapamycin: p<0.0001; torin-1: p<0.0001) compared to control. Column
bars and error bars represent the mean and SD of [n] groups. PVN
paraventricular nucleus, SON supraoptic nucleus. ***p<0.0001
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The role of the p38-, JNK-MAPK, and mTOR pathways
in injury-induced neuronal death
The p38- and JNK-MAPK pathways are structurally simi-
lar, but functionally distinct, from the classic MAPKs
(ERKs). These pathways are preferentially activated by
environmental stresses such as UV radiation, heat and os-
motic shock, and by pro-inflammatory cytokines, such as
tumor necrosis factor (TNF) and interleukin-1 (IL-1)
(Tibbles and Woodgett 1999). Others have demonstrated
that CNTF, which is classified as a pro-inflammatory cy-
tokine, is capable of activating the p38- (Loy et al. 2011)
and the JNK-MAPK pathways (Cagnon and Braissant
2009). Pharmacological inhibition of the p38- and JNK-
MAPK pathways did not affect CNTF-mediated neuronal
survival in hypothalamic organotypic cultures. However,
unexpectedly, when the organotypic cultures were cultured
only in the presence of the inhibitors, there was an increase
in the survival of OT neurons. Similarly, when the
organotypic cultures were cultured only in the presence
of the mTOR inhibitors we observed a similar increase in
the survival of OT neurons. These data suggest that the
p38, JNK, and mTOR signaling components may mediate
the post-axotomy responses that lead to neuronal death in
the organotypic cultures.
Magnocellular vasopressinergic neurons in organotypic
cultures of the PVN undergo neuronal death via apoptosis
(Vutskits et al. 1998). Preparation of the organotypic cultures
used in these studies resulted in a loss of greater than 90 % of
OT neurons (Askvig et al. 2013). Furthermore, the anti-
apoptotic agents, Bcl-xL, and Z-VAD-fmk protect both OT
and VP magnocellular neurons in the SON of organotypic
cultures, (House et al. 2006). These data suggest that the loss
of magnocellular neurons observed in our cultures is likely
due to apoptosis. A well documented function of the p38-
MAPK and JNK-MAPK pathways is their role in the onset
of apoptosis (Cuenda and Rousseau 2007; Dhanasekaran and
Reddy 2008). Moreover, because of the overlap of the MAPK
Ks, specifically MKK4 (Cargnello and Roux 2011), in the
p38-MAPK and JNK-MAPK pathways, these pathways could
be activated by the same stimulus. Thus, our data suggest that
the enhanced survival of the OT neurons that we observed in
the presence of the p38 and JNK inhibitors alone results from
pharmacological inhibition of the apoptotic cascade.
We show that inhibition of mTOR also protects injured OT
neurons in the absence of exogenous rrCNTF. While mTOR
has been primarily linked to the PI3K-AKT pathway, numer-
ous reports have demonstrated mTOR signaling in the MAPK
pathways (Chen et al. 2008; Chen et al. 2011; Karassek et al.
2010; Kato et al. 2012; Miller et al. 2007; Xu et al. 2011). The
Fig. 6 NF-κB is not necessary to mediate the CNTF-induced survival of
OT neurons. Immunohistochemical neuronal cell counts demonstrated
that exogenous rrCNTF promoted the survival of OT neurons (SON: p
<0.0001; PVN: p<0.0001) compared to control, while inhibition of
NF-κB with bay 11-7082 (15 μM: SON: p=0.9228; PVN: p=0.9003;
30 μM: SON: p=0.0828; PVN: p=0.0667) and sc-514 (SON: p=
0.7561; PVN: p=0.3522) did not affect the number of surviving OT
neurons in the SON (a) or PVN (b). However, when cultures were treated
with sc-514 alone, there was a statistically significant increase in the
number of surviving OT neurons in the SON (A; p<0.0001) and PVN
(B; p<0.0001), compared to control. Column bars and error bars repre-
sent the mean and SD of [n] groups. PVN paraventricular nucleus, SON
supraoptic nucleus. **p<0.01, ***p<0.0001
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primary functions of PI3K-AKT-mTOR signaling have been
attributed to promoting process outgrowth, cell survival, pro-
liferation and growth (Chen et al. 2008; Chen et al. 2011;
Karassek et al. 2010; Kato et al. 2012; Miller et al. 2007; Xu
et al. 2011; Zhou and Huang 2010). Paradoxically, mTORC1
signaling has also been shown to mediate apoptosis through
inhibition of AKTand selective activation of the JNK-MAPK
pathway (Kato et al. 2012). These reports suggest that JNK is
capable of mediating an apoptotic response via mTOR, lead-
ing to our hypothesis that following the axotomy during the
organotypic culture preparation the p38- and JNK-MAPK
pathways were co-activated to induce an apoptotic cascade
in the OT neurons through the downstream signaling of
mTOR.
Within the magnocellular neurosecretory system, under-
standing the specific mechanisms that regulate injury-
induced neuronal apoptosis has not been well characterized.
These novel data provide valuable insight into the mecha-
nisms of axotomy-induced cell death that may lead to thera-
pies that promote neuronal survival. Until future in vivo anal-
yses can be performed, the full therapeutic potential remains
unclear.
The role of the PI3K-AKT pathway in CNTF-induced process
outgrowth
In addition to activating the Jak-STAT and MAPK pathways,
reports have also demonstrated that CNTF activates the PI3K-
AKT pathway (Dolcet et al. 2001; Gold et al. 1994; Oh et al.
1998) through a Jak-dependent mechanism (Dolcet et al.
2001). Pharmacological inhibition of PI3K did not affect
CNTF-induced neuronal survival, indicating that CNTF does
not utilize PI3K signaling to promote OT neuronal survival in
the magnocellular neurosecretory system. Interestingly, there
was a remarkable decrease in process outgrowth in the SON
following pharmacological inhibition of PI3K compared to
the CNTF-treated cultures. Although the tissue thickness and
complexity of the processes prevented stereological analysis
of aspects of neurite outgrowth such as elongation, branching,
and neurite caliber, we utilized quantitative optical densito-
metric stereological analysis to determine the proportional ar-
ea of OT-immunoreactive processes which was corrected for
the total number of neurons in the SON. This analysis resulted
in a quantitative, yet conservative, analysis of process-
immunoreactivity which confirmed our visual observation
that there were less OT-immunoreactive processes present in
the SON following PI3K inhibition. Thus, these data demon-
strate that PI3K signaling is involved in regulating CNTF-
mediated process outgrowth, but not involved in mediating
neuronal survival.
It is not surprising that diverse intracellular signaling path-
ways mediate distinct neuroprotective processes in response
to CNTF. Numerous reports have demonstrated divergent
pathway mediation of CNTF-induced neuronal survival and
process outgrowth (Dolcet et al. 2001; Ozog et al. 2008; Park
et al. 2004; Sango et al. 2008). Similarities between those
reports and our own observations indicate that the PI3K-
AKT pathway plays a predominant role in mediating CNTF-
induced process outgrowth in a variety of neuronal pheno-
types. The PI3K-AKT pathway has been well-documented
to promote neuronal survival, however, more recently the
PI3K-AKT pathway has been revealed to be a key regulator
in several aspects of process outgrowth, including elongation,
branching, and neurite caliber (Read and Gorman 2009).
There are many signaling factors downstream of PI3K that
have been demonstrated to influence process outgrowth, in-
cluding; mTORC1 (Asnaghi et al. 2004; Nave et al. 1999) and
NF-κB (Kane et al. 1999; Romashkova and Makarov 1999).
Not surprisingly, the transcriptional products of the PI3K-
AKT pathway that directly mediate process outgrowth are
cytoskeletal elements, such as microtubules (Kobayashi
et al. 1997).
mTOR functions as two distinct signaling complexes,
mTORC1 and mTORC2. These two complexes consist of
unique mTOR-interacting proteins which determine their sub-
strate specificity (Zhou and Huang 2010). Interestingly, the
roles of the mTOR complexes in the PI3K-AKT pathway
are quite distinct. It is believed that mTORC2 functions up-
stream of AKT to assist in regulating maximal activity of
AKT (Hresko and Mueckler 2005; Sarbassov et al. 2005),
while mTORC1 is a downstream regulator of AKT activity
(Zhou and Huang 2010). It was demonstrated that PI3K-AKT-
mTOR signaling has been shown to promote growth and
branching of hippocampal neurons (Jaworski et al. 2005).
Our analysis demonstrated that pharmacological inhibition
of mTORC1 and mTORC2 did not affect OT neuronal sur-
vival or the proportional area of OT-immunoreactive process-
es, suggesting that mTOR is not involved in CNTF-mediated
PI3K-AKT dependent process outgrowth of OT neurons.
NF-κB has also been implicated in mediating process out-
growth downstream of the PI3K-AKT pathway (Armstrong
et al. 2008; Gutierrez et al. 2005; O’Neill and Kaltschmidt
1997; Sole et al. 2004) therefore we sought to determine its
potential role in mediating neuronal survival and process out-
growth in our system. Although our results show that inhibi-
tion of BAY-11-7082 and SC-514 had no affect on process
outgrowth we did observe that inhibition of the IKKβ com-
plex specifically and in the absence of CNTF resulted in a
significant increase in cell survival in both the SON and
PVN. Increased NF-κB activation have been observed in neu-
rons and astrocytes following CNS injury and evidence sug-
gests a dual role for NF-κB in neuronal survival versus neu-
ronal degeneration depending on the type of stimulus or cell
phenotype activated (Mattson). Indeed, consistent with our
observations, selective inactivation of NF-κB in astrocytes
leads to increased survival of retinal ganglion cells following
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ischemia and promotes neuronal survival and axonal
sprouting of central motor neurons following spinal cord in-
jury (Brambilla2005.2009).
Conclusions
We and others have demonstrated previously that exogenous
CNTF will induce magnocellular neuron sprouting in vitro
(Askvig et al. 2013; Vutskits et al. 1998). However, the cellular
signaling pathways mediating this event were not identified. In
this studywe have extended these observations to show that the
PI3K pathway mediates CNTF-induced OT-process outgrowth
in the SON. We also demonstrate here that the MAPK-ERK½
pathway promotes CNTF-induced neuronal survival. Further-
more, we show that the p38-, JNK-MAPK, mTOR and NF-κB
pathways promote magnocellular neuronal survival in the ab-
sence of CNTF following axotomy. Taken together, these data
indicate that distinct intracellular signaling pathways mediate
diverse neuroprotective processes in response to CNTF. The
results of these studies will provide the basis for future studies
that will continue to elucidate the mechanisms underlying
CNTF-mediated neuroprotection and axonal regeneration in
the CNS. Our long-term goal is development of therapeutic
strategies that will allow selective regulation of axonal
sprouting and promote neuronal survival following injuries or
disorders that result in neurodegeneration.
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